Northern Trust’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.7M | Sell |
36,132
-4,497
| -11% | -$1.46M | ﹤0.01% | 2032 |
|
|
2025
Q4 | $12.3M | Buy |
40,629
+17,695
| +77% | +$5.79M | ﹤0.01% | 1969 |
|
|
2025
Q3 | $7.81M | Buy |
22,934
+6,340
| +38% | +$1.93M | ﹤0.01% | 2249 |
|
|
2025
Q2 | $4.02M | Sell |
16,594
-702
| -4% | -$172K | ﹤0.01% | 2582 |
|
|
2025
Q1 | $4.71M | Sell |
17,296
-1,574
| -8% | -$368K | ﹤0.01% | 2441 |
|
|
2024
Q4 | $3.49M | Buy |
18,870
+6,496
| +52% | +$1.33M | ﹤0.01% | 2720 |
|
|
2024
Q3 | $2.78M | Buy |
12,374
+614
| +5% | +$110K | ﹤0.01% | 2796 |
|
|
2024
Q2 | $1.68M | Buy |
11,760
+679
| +6% | +$105K | ﹤0.01% | 2994 |
|
|
2024
Q1 | $1.73M | Buy |
11,081
+1,853
| +20% | +$298K | ﹤0.01% | 3041 |
|
|
2023
Q4 | $1.66M | Buy |
9,228
+524
| +6% | +$94.8K | ﹤0.01% | 3093 |
|
|
2023
Q3 | $1.57M | Sell |
8,704
-462
| -5% | -$91.4K | ﹤0.01% | 3070 |
|
|
2023
Q2 | $1.63M | Buy |
9,166
+232
| +3% | +$53.4K | ﹤0.01% | 3125 |
|
|
2023
Q1 | $1.93M | Sell |
8,934
-25,502
| -74% | -$6.12M | ﹤0.01% | 2954 |
|
|
2022
Q4 | $7.57M | Sell |
34,436
-87,309
| -72% | -$16M | ﹤0.01% | 2203 |
|
|
2022
Q3 | $16.4M | Buy |
121,745
+6,711
| +6% | +$1.15M | ﹤0.01% | 1630 |
|
|
2022
Q2 | $18.6M | Buy |
115,034
+8,231
| +8% | +$1.29M | ﹤0.01% | 1572 |
|
|
2022
Q1 | $20.1M | Sell |
106,803
-7,421
| -6% | -$1.58M | ﹤0.01% | 1672 |
|
|
2021
Q4 | $30.9M | Sell |
114,224
-8,456
| -7% | -$2.86M | 0.01% | 1464 |
|
|
2021
Q3 | $44.5M | Sell |
122,680
-76,320
| -38% | -$25M | 0.01% | 1169 |
|
|
2021
Q2 | $68.3M | Sell |
199,000
-24,742
| -11% | -$8.2M | 0.01% | 890 |
|
|
2021
Q1 | $77.9M | Sell |
223,742
-3,018
| -1% | -$999K | 0.01% | 802 |
|
|
2020
Q4 | $58.6M | Sell |
226,760
-102,261
| -31% | -$28.2M | 0.01% | 948 |
|
|
2020
Q3 | $94.2M | Buy |
329,021
+17,375
| +6% | +$4.08M | 0.02% | 587 |
|
|
2020
Q2 | $58.7M | Buy |
311,646
+326
| +0.1% | +$53.1K | 0.01% | 776 |
|
|
2020
Q1 | $38.3M | Sell |
311,320
-296,854
| -49% | -$46.4M | 0.01% | 939 |
|
|
2019
Q4 | $101M | Buy |
608,174
+9,287
| +2% | +$1.54M | 0.02% | 586 |
|
|
2019
Q3 | $73.3M | Buy |
598,887
+3,973
| +0.7% | +$528K | 0.02% | 695 |
|
|
2019
Q2 | $73.7M | Buy |
594,914
+28,569
| +5% | +$3.63M | 0.02% | 716 |
|
|
2019
Q1 | $74.8M | Sell |
566,345
-78
| -0% | -$10.5K | 0.02% | 688 |
|
|
2018
Q4 | $79.4M | Buy |
566,423
+563,865
| +22,043% | +$74.8M | 0.02% | 596 |
|
|
2018
Q3 | $440K | Buy |
2,558
+308
| +14% | +$51.8K | ﹤0.01% | 3670 |
|
|
2018
Q2 | $346K | Buy |
2,250
+453
| +25% | +$80.8K | ﹤0.01% | 3696 |
|
|
2018
Q1 | $302K | Buy |
+1,797
| New | +$243K | ﹤0.01% | 3703 |
|
Other funds holding ONC
BBA
HA
Northern Trust's ONC Position: Q1 2026 in Review
Northern Trust reduced its BeOne Medicines Ltd (ONC) stake by 11% in Q1 2026, selling an estimated $1.46M and leaving 36,132 shares worth $10.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2032.
Northern Trust first reported a position in ONC in Q1 2018 and has held it in 33 quarters since. The position peaked at $101M in Q4 2019. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.
- Northern Trust held 36,132 shares of BeOne Medicines Ltd worth $10.7M as of Q1 2026.
- Northern Trust sold 4,497 BeOne Medicines Ltd shares in Q1 2026, an estimated $1.46M.
- BeOne Medicines Ltd made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2032 holding.
- Northern Trust first reported a position in BeOne Medicines Ltd in Q1 2018 and has held it in 33 quarters since.
- Northern Trust's BeOne Medicines Ltd position peaked at $101M in Q4 2019.
- 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.